VP
VestibNet Pro
Balance & VestibularUnder Review🇨🇭 NeuroDiag AG, Zurich · Discovered: May 1, 2026 · Source: MedTech Europe
91
AI Score
Device Class
Class IIb
CE Status
✓ Certified
FDA Status
Pending
Price Range
$34K–$52K
Units Sold
~280 global
Key Markets
EU, AUS, CA
Product Description
AI ExtractedVestibNet Pro is a next-generation vestibular diagnostic system combining video head impulse testing (vHIT), video nystagmography (VNG), and AI-assisted posturography in a single integrated platform. The system features a cloud analytics dashboard, EMR integration, and proprietary NeuroBalance AI for differential diagnosis support. Designed for tertiary ENT and neurotology centers.
Why AI Flagged This
CE Mark Class IIb — meets mandatory certification criterionAI 99%
8 clinical studies (n=1,847) — exceeds minimum evidence thresholdAI 96%
Price $34K–$52K — within target range ($5K–$80K)AI 100%
AI-powered differential diagnosis — high innovation score for Taevas portfolioAI 89%
NeuroDiag AG has existing EU distribution but no Asia presenceAI 84%
Fit Score Breakdown
AI ScoredCE/Regulatory Compliance99
Clinical Evidence Quality92
Price/Market Fit81
Portfolio Conflict Risk74
Manufacturer Partnership Potential88
AIAI Recommendation
Strong match — recommend proceeding to formal Due Diligence. CE Mark expires Dec 2027, giving an 18-month window for India+UAE registration. Price point is 15% below EquiTrak Pro — watch for portfolio conflict in India and UAE. Thailand/Singapore low conflict — safe to pursue in parallel.